PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
161.63%
Net income growth at 50-75% of CSIQ's 216.99%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.
-11.90%
Both reduce yoy D&A, with CSIQ at -100.00%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-100.00%
Negative yoy deferred tax while CSIQ stands at 100.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-71.67%
Both cut yoy SBC, with CSIQ at -100.00%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-365.95%
Negative yoy working capital usage while CSIQ is 100.00%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
59.85%
AR growth well above CSIQ's 100.00%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-4.46%
Both reduce yoy inventory, with CSIQ at -100.00%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-40.54%
Both negative yoy AP, with CSIQ at -100.00%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-589.33%
Both reduce yoy usage, with CSIQ at -100.00%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
111.65%
Well above CSIQ's 77.97%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-431.41%
Negative yoy CFO while CSIQ is 100.00%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-63.82%
Negative yoy CapEx while CSIQ is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
62.75%
Purchases growth of 62.75% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
11.99%
Liquidation growth of 11.99% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-43.93%
We reduce yoy other investing while CSIQ is 100.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
36.96%
Lower net investing outflow yoy vs. CSIQ's 100.00%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
No Data
No Data available this quarter, please select a different quarter.
100.00%
We slightly raise equity while CSIQ is negative at -100.00%. John Neff sees competitor possibly preserving share count or buying back shares.
No Data
No Data available this quarter, please select a different quarter.